PYVLX
Price
$17.19
Change
-$0.04 (-0.23%)
Updated
Sep 5 closing price
Net Assets
1.04B
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

PYVLX vs VVIAX

Header iconPYVLX vs VVIAX Comparison
Open Charts PYVLX vs VVIAXBanner chart's image
Payden Equity Income
Price$17.19
Change-$0.04 (-0.23%)
VolumeN/A
Net Assets1.04B
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
PYVLX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PYVLX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYVLX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. PYVLX (1.04B). VVIAX pays higher dividends than PYVLX: VVIAX (2.10) vs PYVLX (1.03). PYVLX was incepted earlier than VVIAX: PYVLX (29 years) vs VVIAX (25 years). PYVLX (0.76) is less costly to investors than VVIAX (0.05). PYVLX is a more actively managed with annual turnover of: 80.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than PYVLX: VVIAX (3000) vs PYVLX (100000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. PYVLX (-5.55). VVIAX return over 5 years is better than : 70.16 vs. PYVLX (13.11).
PYVLXVVIAXPYVLX / VVIAX
Total Expense Ratio0.760.051,520%
Annual Report Gross Expense Ratio0.760.051,520%
Fund Existence29 years25 years-
Gain YTD6.7667.85086%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B203B1%
Annual Yield % from dividends1.032.1049%
Returns for 1 year-5.557.74-72%
Returns for 3 years8.1536.6122%
Returns for 5 years13.1170.1619%
Returns for 10 years59.43131.6145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV1.330.03
+2.31%
Acrivon Therapeutics
LEG10.010.22
+2.25%
Leggett & Platt
TMO492.603.11
+0.64%
Thermo Fisher Scientific
AMG230.28-2.77
-1.19%
Affiliated Managers Group
LFMD6.06-0.22
-3.50%
LifeMD